BV6 | cIAP inhibitor - InvivoGen
Buy high-quality BV6, a potent and selective inhibitor of cIAP1, cIAP2, and XIAP. Functionally validated in TNF-α-induced necroptosis cellular assays. Each lot is highly pure (≥95%) and …
This technical guide provides a comprehensive overview of the function of BV6 in oncology, detailing its mechanism of action, summarizing key preclinical data, and outlining experimental …
BV6, an IAP antagonist, activates apoptosis and enhances ...
Defects in the apoptosis pathway limit the effectiveness of radiation in non-small cell lung cancer (NSCLC) therapy. BV6 is an antagonist of cIAP1 and XIAP, members of the inhibitors of …
BV6 | cIAP1/XIAP Antagonist | MedChemExpress
BV6 is an antagonist of cIAP1 and XIAP, members of the inhibitors of apoptosis (IAP) family.
BV-6 | IAP inhibitor | CAS 1001600-56-1 | dual inhibitor of cIAP ...
BV-6 is a novel and potent SMAC (second mitochondrial-derived activator of caspases)mimetic, and a dual inhibitor of cIAP (inhibitor of apoptosis) and XIAP (X-linked inhibitor of apoptosis) …
- Reviews: 1
BV-6 cIAP/XIAP Antagonist | Selleck Chemicals
BV-6 is a SMAC mimetic, dual cIAP and XIAP inhibitor. (Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.) Validated by Selleck labs. Should you need …
- Reviews: 76
BV6 |CAS:1001600-56-1 Probechem Biochemicals
BV6 is a small molecule, bivalent IAP antagonist that binds to the c-IAP1 and XIAP BIR2-BIR3 domains with Kd of 0.46 and 0.029 nM, respectively. BV6 treatment results in dramatic …
BV6 (CAS Number: 1001600-56-1) | Cayman Chemical
BV6: A bivalent Smac mimetic and IAP antagonist. CAS Number: 1001600-56-1. Purity: ≥98%.
BV-6 | CAS#:1001600-56-1 | Chemsrc
Aug 25, 2025 · Use of BV-6 BV6 is an antagonist of cIAP1 and XIAP, members of the inhibitors of apoptosis (IAP) family.
BV6, an IAP Antagonist, Activates Apoptosis and Enhances ...
Defects in the apoptosis pathway limit the effectiveness of radiation in non-small cell lung cancer (NSCLC) therapy. BV6 is an antagonist of cIAP1 and XIAP, members of the inhibitors of …